Total Funding
64
63
Total FundingSeries A raised
Growth Score
-5 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
152889
Empros Pharma develops pharmaceutical treatments against overweight and obesity.
- Arvid Söderhäll: Chief Executive Officer & Managing DirectorPast Role: Sweden Bio, Chairman of working group for clinical trials and regulatory issues
About the Company
Empros Pharma develops pharmaceutical treatments against overweight and obesity. The company's troubling obesity-related trends overweight children and adolescents during the last decades. The reimbursement system is undergoing a change where pharmaceutical treatments of obesity. The company developed a revolutionary oral drug.
